Suvretta Capital Management »

Miragen Therapeutics shares owned by Suvretta Capital Management

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Suvretta Capital Management from 13F filings

Historical chart of Suvretta Capital Management investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Suvretta Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $520k 17k 31.12

More positions owned by Suvretta Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Arcutis Biotherapeutics (ARQT)
Ark Etf Tr Genomic Rev Etf Put Option (ARKG)
Benitec Biopharma Com New (BNTC)
Legend Biotech Corp Sponsored Ads (LEGN)
Eyepoint Com New (EYPT)
Arcus Biosciences Incorporated (RCUS)
Immatics SHS (IMTX)
Biohaven (BHVN)
Meta Platforms Cl A (META)
Apellis Pharmaceuticals (APLS)
NVIDIA Corporation (NVDA)
Coca-Cola Company (KO)
Ge Aerospace Com New (GE)
Amazon (AMZN)

View all positions for Suvretta Capital Management

Top funds holding Miragen Therapeutics

FMR
BlackRock
Vanguard Group
Bellevue Group
Fairmount Funds Management
VR Adviser
State Street Corporation
Deep Track Capital
Novo A/S
Geode Capital Management
Alliancebernstein
Tang Capital Management
Eversept Partners
Fisher Investments
Baker Bros. Advisors

View all funds holding Miragen Therapeutics